Prognostic value of plasma interleukin-6 concentrations and the −174 G > C and −572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis

This publication has 30 references indexed in Scilit:

• The interleukin-6 −174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men
  European Heart Journal, 2001
• Interleukin-6 Gene −174G>C and −572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease
  New England Journal of Medicine, 2000
• Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation
  Journal of Biological Chemistry, 2000
• Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
  Atherosclerosis, 2000
• Atherosclerosis — An Inflammatory Disease
  New England Journal of Medicine, 1999
• The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
  Journal of Clinical Investigation, 1998
• Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
  The American Journal of Cardiology, 1996
• Interleukin-6: An Overview
  Annual Review of Immunology, 1990
• Evaluation of methods for quantitating left ventricular segmental wall motion in man using myocardial markers as a standard.
  Circulation, 1980